EP44: Clots And Drugs

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Summary: EP44 - Clots And Drugs Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he responds to a Facebook question about blood-thinning medications, specifically warfarin and Prasugrel, by explaining how different drug classes work to prevent clot formation in the body. The episode provides a foundational understanding of antiplatelet agents versus anticoagulants and when each type is used. Key Takeaways: Clot formation in the body is driven by two main mechanisms: platelets (small sticky blood components) and the coagulation cascade (proteins that form clots) Antiplatelet drugs like aspirin, clopidogrel, ticagrelor, and Prasugrel prevent platelets from clumping together and are primarily used in the arterial system, such as in stents and for coronary artery disease Anticoagulant drugs work by thinning the blood through the coagulation cascade and are used to affect the proteins involved in clot formation Warfarin is the historically most widely used anticoagulant, but newer alternatives called NOACs (non-vitamin K dependent oral anticoagulants) have entered the market with different mechanisms of action The three main NOAC medications currently available are rivaroxaban (Xarelto), dabigatran (Pradaxa), and apixaban (Eliquis) NOACs target specific parts of the coagulation cascade differently than warfarin, offering patients alternative blood-thinning options Understanding which drug class addresses platelets versus proteins in clot formation helps patients and doctors select appropriate treatments for their specific conditions